| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| ADH1C |
P00326
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
Enzyme
|
|
0.547 |
0.731 |
| CMM |
|
cutaneous malignant melanoma/dysplastic nevus
|
|
|
0.670 |
0.385 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| ND2 |
P03891
|
MTND2
|
|
|
0.601 |
0.615 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| PRSS2 |
P07478
|
serine protease 2
|
Enzyme
|
|
0.628 |
0.769 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
| SRY |
Q05066
|
sex determining region Y
|
Transcription factor
|
|
0.456 |
0.808 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |